Linguamatics releases I2E. Version 3.2 software for pharmaceutical companies

NewsGuard 100/100 Score

Linguamatics, the leader in NLP-based enterprise text mining for life sciences and other markets, announces the latest release of its award-winning software platform, I2E. Version 3.2 reflects Linguamatics' commitment to continuing innovation, and offers significant developments in the areas of improved performance, query power enhancements, and simplicity of use. These new capabilities are now available to the company's extensive user base in the life sciences sector, which includes the world's top-10 pharmaceutical companies.

I2E 3.2 provides users with a host of additional features to rapidly and effectively get to the answers they are looking for. Customer feedback has indicated that I2E finds meaningful information over ten times faster than conventional search engine-based approaches. I2E 3.2 provides this by indexing the data faster, providing more powerful querying tools and reducing the considerable amount of irrelevant, "noisy" data which often hampers the research effort.

"Linguamatics continues to build on its core strengths of text mining and Natural Language Processing. We demonstrate through regular innovation our ability to respond to the expanding needs of a demanding, sophisticated customer base", commented John M. Brimacombe, Executive Chairman of Linguamatics. "Our customer growth and retention continues to be excellent as they prove the value of agile text mining to inform decision-makers across their organizations, and exploit the technology in more applications. We continue to set the standard for agile text mining that directly drives decision making."

Linguamatics continues to invest in building and enhancing powerful text mining capabilities, which enable research and development functions to reengineer and optimise their handling and interpretation of vast quantities of relevant, but often unstructured, data. This is exemplified in the recent launch of I2E OnDemand. This Software as a Service (SaaS) version of I2E enables small to medium sized organisations to access the same powerful NLP based querying, information extraction and knowledge synthesis capabilities contained in the enterprise version of I2E.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Common HIV drugs linked to reduced Alzheimer's disease risk